Trilostane

CAS 13647-35-3

In Stock

Trilostane

Cat. No. ANT-TRL-000CAS 13647-35-3In Stock

Technical Data

Cat. No.ANT-TRL-000

CAS13647-35-3

Mol. FormulaC₂₀H₂₇NO₃

Mol. Weight329.43 g/mol

IUPAC(1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile

SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C

InChIInChI=1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1

InChI KeyKVJXBPDAXMEYOA-CXANFOAXSA-N

Purity99%

Description

Overview

Trilostane has been used in the treatment of Cushing's syndrome (hypercortisolism), Conn's syndrome (hyperaldosteronism), and postmenopausal breast cancer in humans. When used to treat breast cancer, trilostane is administered in combination with a corticosteroid to prevent glucocorticoid deficiency

Anant Labs manufacture and furnish high quality Trilostane impurities for global markets. Our Trilostane EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

(4alpha,5alpha,17beta)-4,5-Epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrileTrilostane13647-35-3ModrenalVetorylDesopanModrastaneTrilostanoWin-24540Trilostanum

Browse APIs A–Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Impurities (1)

Impurity

Trilostane

Cat. No.: ANT-TRL-000

In StockRFQ

Trilostane

Trilostane

Overview

Synonyms

Impurities (1)

Trilostane

Looking for a specific reference standard?